X-53592404-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BS1BS2

The NM_031407.7(HUWE1):​c.3966G>A​(p.Leu1322Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000238 in 1,199,546 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 59 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., 25 hem., cov: 22)
Exomes 𝑓: 0.00014 ( 0 hom. 34 hem. )

Consequence

HUWE1
NM_031407.7 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -0.508

Publications

0 publications found
Variant links:
Genes affected
HUWE1 (HGNC:30892): (HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1) This gene encodes a protein containing a C-terminal HECT (E6AP type E3 ubiquitin protein ligase) domain that functions as an E3 ubiquitin ligase. The encoded protein is required for the ubiquitination and subsequent degradation of the anti-apoptotic protein Mcl1 (myeloid cell leukemia sequence 1 (BCL2-related)). This protein also ubiquitinates the p53 tumor suppressor, core histones, and DNA polymerase beta. Mutations in this gene are associated with Turner type X-linked syndromic cognitive disability. [provided by RefSeq, Aug 2013]
HUWE1 Gene-Disease associations (from GenCC):
  • intellectual disability, X-linked syndromic, Turner type
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics, G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.073).
BP6
Variant X-53592404-C-T is Benign according to our data. Variant chrX-53592404-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 211165.
BP7
Synonymous conserved (PhyloP=-0.508 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00117 (130/111290) while in subpopulation AFR AF = 0.00402 (123/30607). AF 95% confidence interval is 0.00344. There are 0 homozygotes in GnomAd4. There are 25 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High AC in GnomAd4 at 130 XL,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_031407.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HUWE1
NM_031407.7
MANE Select
c.3966G>Ap.Leu1322Leu
synonymous
Exon 33 of 84NP_113584.3
HUWE1
NM_001441057.1
c.3966G>Ap.Leu1322Leu
synonymous
Exon 32 of 83NP_001427986.1
HUWE1
NM_001441051.1
c.3966G>Ap.Leu1322Leu
synonymous
Exon 33 of 84NP_001427980.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HUWE1
ENST00000262854.11
TSL:1 MANE Select
c.3966G>Ap.Leu1322Leu
synonymous
Exon 33 of 84ENSP00000262854.6
HUWE1
ENST00000342160.7
TSL:5
c.3966G>Ap.Leu1322Leu
synonymous
Exon 32 of 83ENSP00000340648.3
HUWE1
ENST00000612484.4
TSL:5
c.3939G>Ap.Leu1313Leu
synonymous
Exon 30 of 81ENSP00000479451.1

Frequencies

GnomAD3 genomes
AF:
0.00117
AC:
130
AN:
111236
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00403
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000475
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00134
GnomAD2 exomes
AF:
0.000313
AC:
57
AN:
182008
AF XY:
0.000210
show subpopulations
Gnomad AFR exome
AF:
0.00388
Gnomad AMR exome
AF:
0.000182
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000221
GnomAD4 exome
AF:
0.000142
AC:
155
AN:
1088256
Hom.:
0
Cov.:
29
AF XY:
0.0000959
AC XY:
34
AN XY:
354614
show subpopulations
African (AFR)
AF:
0.00412
AC:
108
AN:
26240
American (AMR)
AF:
0.000369
AC:
13
AN:
35203
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19329
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53929
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39725
Middle Eastern (MID)
AF:
0.00121
AC:
5
AN:
4116
European-Non Finnish (NFE)
AF:
0.00000240
AC:
2
AN:
833710
Other (OTH)
AF:
0.000589
AC:
27
AN:
45826
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00117
AC:
130
AN:
111290
Hom.:
0
Cov.:
22
AF XY:
0.000747
AC XY:
25
AN XY:
33482
show subpopulations
African (AFR)
AF:
0.00402
AC:
123
AN:
30607
American (AMR)
AF:
0.000474
AC:
5
AN:
10544
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2640
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3540
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2560
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6010
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
52979
Other (OTH)
AF:
0.00132
AC:
2
AN:
1510
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000347
Hom.:
0
Bravo
AF:
0.00139
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 09, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 02, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Uncertain:1
Apr 23, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Dec 23, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
1.7
DANN
Benign
0.68
PhyloP100
-0.51
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140959967; hg19: chrX-53619364; API